[Home]   [Full version]  

Pill helps boost abortions in Britain

May 29 ,Medicine & Health


Britain's independent abortion provider BPAS says the early medical abortion pill accounted for nearly a third of 32,000 pregnancy terminations last year.

A record 10,000 women had abortions in their own homes during the first nine weeks of pregnancy, says the agency.

The head of the agency says demand for the EMA pill has surged after BPAS started allowing women to go home after the second dose, reports The Times of London.

The Times said anti-abortion campaigners have condemned the procedure, claiming such abortions have been linked with the deaths of 10 women.

The abortion pill is given in two stages. A woman must go to a clinic to take the first oral dose of a drug called mifepristone or RU486, which blocks pregnancy hormones. After two days, the woman comes for a second drug which triggers a miscarriage after a few hours. Those who support the procedure say being able to go home to have the miscarriage gives a woman more control over an extremely personal issue, the newspaper said.

Copyright 2006 by United Press International

Related stories:

The surprising power of the pill
Women who have tried to conceive using in vitro fertilization (IVF) methods are painfully aware that timing is of the essence. There are cancelled vacations, too many sick days taken from work, and the necessity to plan everything around “the treatment.”
Weight fixation sends unhealthy messages
Making assumptions of health based on a person’s weight is faulty, and misinformation is putting people’s physical and emotional well-being at risk, says College of Education researcher and lecturer in human development Dr Cat Pausé.
Research shows that the pill does not deserve its reputation for causing weight gain
Research has not proven that the Pill causes weight gain. But many women are put off using contraceptive pills because this has been listed as one of their adverse effects. Their concern may be narrowing their contraceptive choices without good reason, according to the German Institute for Quality and Efficiency in Health Care (IQWiG). Different forms of contraception have other advantages and disadvantages that need to be weighed up for each individual. The Institute has assessed the research on several current issues in contraception and weight control and has now published easy-to-understand information about this on its website informedhealthonline.org.
A nasty bug, an effective (but yucky) cure
Dr. Johannes Aas was stumped. The patient in his Duluth, Minn., clinic was not responding to antibiotics, and now the stubborn infection in his intestines threatened to kill him. Then Aas found a similar case written up in a 1950s Norwegian medical journal.
Rutgers scholar authors definitive biography of reproductive medicine pioneer
As Louise Brown – the first baby conceived by in vitro fertilization – celebrates her 30th birthday in 2008, a new book coauthored by a Rutgers medical historian offers the first comprehensive insight into the influence of John Rock, the Harvard-affiliated gynecologist and pioneering researcher, in shaping the field of modern reproductive medicine.
Stem cells may solve mystery of early pregnancy breast cancer protection
The answer to why an early pregnancy seems to protect against breast cancer could rest with a decrease in stem cells found after animals have given birth, said researchers at Baylor College of Medicine in a report that appears in the current issue of the journal Stem Cell.
Education needed to decrease teens' misconception about emergency contraception
Targeted health education may help urban, minority adolescent women better understand how the emergency contraception pill works and eliminate some misconceptions about side effects, confidentiality and accessibility, according to a study by The Children's Hospital of Philadelphia.
HIV prevention researchers to compare common ARV as a pill and vaginal gel in unique study
In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.

News discussion:

Medicine & Health news

[Home]   [Full version]